Brief: Akoya Biosciences Q2 Revenue USD 23.2 Million Vs. IBES Estimate USD 23.6 Million
05/08/2024 21:00
Aug 05 (Reuters) - Akoya Biosciences Q2 gross margin 57.8%. * outlook FY revenue USD 96-104 million
Recent news on Akoya Biosciences
See all newsBrief: Akoya Biosciences Inc - On May 20, Receives Unsolicited Acquisition Proposal At $1.40 Per Share From A Third Party- SEC Filing
Akoya Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Akoya Biosciences Q1 Gross Margin 59.3%
Akoya Biosciences Inc expected to post a loss of 20 cents a share - Earnings Preview
Leerink Partners downgrades Quanterix to 'market perform' on Akoya deal risks